Tyrogenex Secures $543,952 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e458b4ad-5f9e-4967-95fb-cb8c0bba1d1a
Date
2/29/2016
Company Name
Tyrogenex
Mailing Address
197 1st Avenue Needham Heights, MA 02494 USA
Company Description
Founded in 2006, Tyrogenex is comprised of an experienced team that is dedicated to advancing next generation targeted therapeutics as promising new treatments to improve the lives of cancer patients.
Website
http://www.xcovery.com
Transaction Type
Venture Equity
Transaction Amount
$543,952
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 18 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed